Takeda Loosens Contract Pharmacy Restrictions on Arkansas Hospitals

Takeda has loosened its 340B contract pharmacy restrictions for Arkansas-based hospital covered entities.
Editors’ note: After publication, Pfizer became the 24th drugmaker to loosen or end its contract pharmacy restrictions for Arkansas covered entities, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

In Victory for Drug Industry, Kansas Legislature Pauses New 340B Contract Pharmacy Law, Sending Issue Back to the Governor

Kansas lawmakers voted late Tuesday for a long-term pause of a recently enacted contract pharmacy law.
Just weeks after passing legislation to prohibit drugmaker 340B contract pharmacy restrictions in the state, Kansas lawmakers voted late Tuesday [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Louisiana AG, Health Centers Defend 340B Contract Pharmacy Law in Response to Drugmaker Suit

Louisiana Attorney General Liz Murrill (R) and a state provider group each filed response briefs to drugmaker AbbVie in a case challenging Louisiana's 340B contract pharmacy access law.
Louisiana Attorney General Liz Murrill (R) and a state provider group each filed response briefs to drugmaker AbbVie in a case challenging Louisiana's 340B contract pharmacy access law.
Louisiana’s 340B contract pharmacy access law is constitutional because it governs drug distribution and not pricing, a state official and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Cosette Pharmaceuticals Offers 340B Provider Refunds on 38 Drugs

North Carolina-based drug manufacturer Cosette will refund 340B providers for 38 medications.
Cosette Pharmaceuticals recently announced refunds to 340B covered entities for 38 medications sold over a year and half. The refunds [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Bausch Health Becomes 22nd Drugmaker to End or Loosen 340B Contract Pharmacy Restrictions in Arkansas

Drugmaker Bausch Health has exempted all Arkansas covered entities from its 340B contract pharmacy restrictions in response to a state law recently upheld by a federal appeals court.
Drug manufacturer Bausch Health announced it will exempt all Arkansas providers and pharmacies from its 340B contract pharmacy policy, including [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Takeda Issues Refunds to 340B Providers for 28 Drugs

Drugmaker Takeda is offering rebates to 340B providers on 28 of its drugs.
Japanese drugmaker Takeda recently announced refunds to 340B covered entities for 28 drugs, including one of its top-selling attention-deficit medications. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Attorneys Expect Many Filings under Newly Reconstituted 340B Dispute Resolution Process

Kyle Vasquez, an attorney for Polsinelli, said he expects a "wave of filings" under HRSA's latest ADR rule because it is more flexible than the prior process.
Attorneys for both covered entities and drug manufacturers say they expect a significant number of filings to the newly re-established [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novartis to Refund Covered Entities After Adjusting 340B Ceiling Prices for 100-Plus Products

Drugmaker Novartis has announced it will refund 340B providers for more than 100 products after adjusting their 340B ceiling prices.
Thousands of covered entities that purchased more than one hundred Novartis products between late 2019 and early 2023 will be [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Providers Generally Supportive, PhRMA Pans Final 340B Dispute Resolution Rule

After HHS released the long-awaited final rule for resolving 340B administrative disputes, provider groups generally supported and PhRMA denounced the updated process.
Provider advocates celebrated—with some reservations—the recently issued final rule reshaping the Administrative Dispute Resolution (ADR) process for 340B stakeholders. On [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AbbVie, BI Agree to Lift 340B Contract Pharmacy Restrictions in Arkansas, Making It 21 Manufacturers to End or Loosen Restrictions

Boehringer Ingelheim became one of the latest major drugmakers to exempt Arkansas covered entities from its 340B contract pharmacy restrictions.
Drugmakers AbbVie and Boehringer Ingelheim (BI) have agreed in principle to exempt Arkansas providers from their 340B contract pharmacy restrictions, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live